Immuneering Corp (NASDAQ: IMRX) on Monday, plunged -6.39% from the previous trading day, before settling in for the closing price of $2.66. Within the past 52 weeks, IMRX’s price has moved between $1.00 and $9.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -43.59%. The company achieved an average annual earnings per share of -0.30%. With a float of $21.00 million, this company’s outstanding shares have now reached $29.27 million.
Let’s determine the extent of company efficiency that accounts for 68 employees.
Immuneering Corp (IMRX) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Immuneering Corp is 29.18%, while institutional ownership is 32.39%. The most recent insider transaction that took place on Apr 01 ’24, was worth 1,160,181. In this transaction 10% Owner of this company sold 400,000 shares at a rate of $2.90, taking the stock ownership to the 2,895,273 shares. Before that another transaction happened on Mar 22 ’24, when Company’s Director bought 2,900 for $2.55, making the entire transaction worth $7,385. This insider now owns 2,900 shares in total.
Immuneering Corp (IMRX) Earnings and Forecasts
#####
According to the Wall Street analysts, stocks earnings will be around -0.30% per share during the next fiscal year.
Immuneering Corp (NASDAQ: IMRX) Trading Performance Indicators
Immuneering Corp (IMRX) is currently performing well based on its current performance indicators. A quick ratio of 9.39 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.91, a number that is poised to hit -0.55 in the next quarter and is forecasted to reach -1.64 in one year’s time.
Technical Analysis of Immuneering Corp (IMRX)
Looking closely at Immuneering Corp (NASDAQ: IMRX), its last 5-days average volume was 2.48 million, which is a jump from its year-to-date volume of 2.44 million. As of the previous 9 days, the stock’s Stochastic %D was 29.30%. Additionally, its Average True Range was 0.42.
During the past 100 days, Immuneering Corp’s (IMRX) raw stochastic average was set at 52.65%, which indicates a significant increase from 49.43% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 258.05% in the past 14 days, which was higher than the 133.17% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.53, while its 200-day Moving Average is $3.14. However, in the short run, Immuneering Corp’s stock first resistance to watch stands at $2.64. Second resistance stands at $2.80. The third major resistance level sits at $2.90. If the price goes on to break the first support level at $2.39, it is likely to go to the next support level at $2.29. Should the price break the second support level, the third support level stands at $2.13.
Immuneering Corp (NASDAQ: IMRX) Key Stats
Market capitalization of the company is 73.83 million based on 29,653K outstanding shares. Right now, sales total 0 K and income totals -53,470 K. The company made 0 K in profit during its latest quarter, and -14,080 K in sales during its previous quarter.
